OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder
Falk W. Lohoff, Jill L. Sorcher, Allison D. Rosen, et al.
Molecular Psychiatry (2017) Vol. 23, Iss. 9, pp. 1900-1910
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Mendelian Randomization Study of PCSK9 and HMG-CoA Reductase Inhibition and Cognitive Function
Daniel B. Rosoff, Andrew S. Bell, Jeesun Jung, et al.
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 7, pp. 653-662
Open Access | Times Cited: 82

Genetics of substance use disorders in the era of big data
Joel Gelernter, Renato Polimanti
Nature Reviews Genetics (2021) Vol. 22, Iss. 11, pp. 712-729
Open Access | Times Cited: 95

DNA methylation age is accelerated in alcohol dependence
Allison D. Rosen, Keith D. Robertson, Ryan A. Hlady, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 92

Epigenetic aging is accelerated in alcohol use disorder and regulated by genetic variation in APOL2
Audrey Luo, Jeesun Jung, Martha Longley, et al.
Neuropsychopharmacology (2019) Vol. 45, Iss. 2, pp. 327-336
Open Access | Times Cited: 87

Smoking and blood DNA methylation: an epigenome-wide association study and assessment of reversibility
Pierre‐Antoine Dugué, Chol-Hee Jung, Jihoon E. Joo, et al.
Epigenetics (2019) Vol. 15, Iss. 4, pp. 358-368
Open Access | Times Cited: 76

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in the Brain and Relevance for Neuropsychiatric Disorders
Emma M. O’Connell, Falk W. Lohoff
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 74

Regulation of PCSK9 Expression and Function: Mechanisms and Therapeutic Implications
Xiao-dan Xia, Zhongsheng Peng, Hongmei Gu, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 63

A promising therapy for fatty liver disease: PCSK9 inhibitors
Lizhu Han, Liuyun Wu, Qinan Yin, et al.
Phytomedicine (2024) Vol. 128, pp. 155505-155505
Closed Access | Times Cited: 8

Alcohol consumption is associated with widespread changes in blood DNA methylation: Analysis of cross‐sectional and longitudinal data
Pierre‐Antoine Dugué, Rory Wilson, Benjamin Lehne, et al.
Addiction Biology (2019) Vol. 26, Iss. 1
Open Access | Times Cited: 71

PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease
Ji Soo Lee, Partha Mukhopadhyay, Csaba Mátyás, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 69

Wine and its metabolic effects. A comprehensive review of clinical trials
Elizabeth Fragopoulou, Maria Choleva, Smaragdi Antonopoulou, et al.
Metabolism (2018) Vol. 83, pp. 102-119
Closed Access | Times Cited: 64

Epigenetics of alcohol use disorder—A review of recent advances in DNA methylation profiling
Martha Longley, Jisoo Lee, Jeesun Jung, et al.
Addiction Biology (2021) Vol. 26, Iss. 6
Open Access | Times Cited: 43

Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the central nervous system
Andrew S. Bell, Josephin Wagner, Daniel B. Rosoff, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105155-105155
Closed Access | Times Cited: 20

PCSK9 inhibition attenuates alcohol-associated neuronal oxidative stress and cellular injury
Josephin Wagner, Lauren M. Park, Partha Mukhopadhyay, et al.
Brain Behavior and Immunity (2024) Vol. 119, pp. 494-506
Open Access | Times Cited: 5

Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization Study
Jahad Alghamdi, Sabine Matou‐Nasri, Faisal Alghamdi, et al.
The International Journal of Neuropsychopharmacology (2018) Vol. 21, Iss. 12, pp. 1067-1075
Open Access | Times Cited: 37

PCSK9 and the Gut-Liver-Brain Axis: A Novel Therapeutic Target for Immune Regulation in Alcohol Use Disorder
Ji Soo Lee, Emma M. O’Connell, Pál Pacher, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 8, pp. 1758-1758
Open Access | Times Cited: 26

Post-translational modifications of histone and non-histone proteins in epigenetic regulation and translational applications in alcohol-associated liver disease: Challenges and research opportunities
Wiramon Rungratanawanich, Jacob W. Ballway, Xin Wang, et al.
Pharmacology & Therapeutics (2023) Vol. 251, pp. 108547-108547
Closed Access | Times Cited: 9

The ever-expanding saga of the proprotein convertases and their roles in body homeostasis: emphasis on novel proprotein convertase subtilisin kexin number 9 functions and regulation
Nabil G. Seidah, Michel Chrètien, Majambu Mbikay
Current Opinion in Lipidology (2018) Vol. 29, Iss. 2, pp. 144-150
Closed Access | Times Cited: 31

Gene × Environment Interaction in Developmental Disorders: Where Do We Stand and What’s Next?
Gianluca Esposito, Atiqah Azhari, Jessica L. Borelli
Frontiers in Psychology (2018) Vol. 9
Open Access | Times Cited: 29

Acute alcohol withdrawal and recovery in men lead to profound changes in DNA methylation profiles: a longitudinal clinical study
Stephanie H. Witt, Josef Frank, Ulrich Frischknecht, et al.
Addiction (2020) Vol. 115, Iss. 11, pp. 2034-2044
Open Access | Times Cited: 26

Associations of Alcohol Consumption With Epigenome‐Wide DNA Methylation and Epigenetic Age Acceleration: Individual‐Level and Co‐twin Comparison Analyses
Mallory Stephenson, Sailalitha Bollepalli, Emma Cazaly, et al.
Alcoholism Clinical and Experimental Research (2020) Vol. 45, Iss. 2, pp. 318-328
Open Access | Times Cited: 26

Pharmacotherapies and Personalized Medicine for Alcohol Use Disorder: A Review
Falk W. Lohoff
Pharmacogenomics (2020) Vol. 21, Iss. 15, pp. 1117-1138
Open Access | Times Cited: 25

Page 1 - Next Page

Scroll to top